PillMetoclopramide
Metoclopramide Hydrochloride
6 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 4 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 3 | SUPPLYING |
| Teva Parenteral Medicines, Inc. | unknown | 2 | SUPPLYING |
| Hospira, Inc. | unknown | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 29, 2021RECALLRecall (Class II): Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine…
Lack of Assurance of Sterility — Recalling firm: Teva Pharmaceuticals USA — Product was distributed Nationwide, including Puerto Rico.
- Apr 26, 2021RECALLRecall (Class II): Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvi…
Lack of Assurance of Sterility — Recalling firm: Teva Pharmaceuticals USA — Product was distributed nationwide.
- Feb 15, 2021RECALLRecall (Class II): Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceutic…
Chemical contamination; Unknown brown residue adhering to the inside of one vial. — Recalling firm: Teva Pharmaceuticals USA — Nationwide, including Puerto Rico
- Feb 10, 2021RECALLRecall (Class II): Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Singl…
Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products. — Recalling firm: Teva Pharmaceuticals USA — Product was distributed nationwide in the USA and Puerto Rico.
- Sep 24, 2013RECALLRecall (Class II): Metoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest, IL, 6…
Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico